한글목차

옥시코돈 염산염 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 43억 2,000만 달러에서 2026년에는 44억 9,000만 달러에 이르고, CAGR 4.0%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 통증 질환의 유병률 증가, 수술 후 치료에서 오피오이드의 광범위한 사용, 대체 통증 치료법의 제한된 가용성, 병원 기반의 강력한 처방 관행, 확립된 경구용 오피오이드 제제 등에 기인하는 것으로 추정됩니다.

옥시코돈 염산염 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 51억 8,000만 달러에 이르고, CAGR은 3.6%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 오남용 방지 및 변조 방지 제제 개발, 오피오이드 사용 관리 및 규제에 대한 관심 증가, 제네릭 의약품 제조 확대, 암 발병률 증가 및 완화 치료 수요 증가, 통증 관리 전달 시스템 혁신 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 효과적인 통증 관리 요법에 대한 수요 증가, 서방형 및 오남용 방지 제제의 사용 확대, 수술 후 통증 및 암 관련 통증에 대한 처방 증가, 제네릭 및 비용 효율적인 오피오이드 제제로의 전환, 규제 감시 강화 및 통제된 유통 시스템 구축 등이 있습니다. 등을 꼽을 수 있습니다.

향후 몇 년 동안 만성 통증의 유병률 증가가 옥시코돈 염산염 시장의 성장을 견인할 것으로 예측됩니다. 3개월 이상 지속되는 통증으로 정의되는 만성통증은 환자의 삶의 질에 심각한 영향을 미치며, 효과적인 통증 관리 솔루션에 대한 수요 증가에 기여하고 있습니다. 만성 통증 사례 증가는 주로 비만, 고령화, 근골격계 질환 등의 요인과 관련이 있으며, 이는 골관절염, 요통 등의 질병 발생률을 증가시키고 있습니다. 옥시코돈 염산염은 신경계 내 통증 수용체에 작용하여 만성 통증 관리를 돕고, 중등도에서 중증의 통증 완화를 가져와 환자의 편안함과 일상 생활 기능 향상에 기여합니다. 예를 들어, 미국 연방기관인 국립보건통계센터(NCHS)의 2024년 11월 기준 자료에 따르면 미국 성인의 24.3%가 만성 통증을 경험하고 있으며, 그 중 8.5%는 일상 생활이나 업무 활동을 제한하는 고강도 만성 통증을 경험하고 있다고 보고했습니다. 따라서 만성 통증의 유병률 증가는 옥시코돈 염산염 시장의 성장을 가속하고 있습니다.

옥시코돈 염산염 시장에서 활동하는 주요 기업들은 오피오이드 중독과 관련된 위험을 최소화하면서 통증 관리 결과를 개선하기 위해 복합 요법 등 첨단 제제 개발에 집중하고 있습니다. 복합요법이란 치료 효과를 높이거나 여러 통증 경로에 대응하고 부작용을 줄이기 위해 두 가지 이상의 약물을 병용하는 것을 말합니다. 예를 들어, 2025년 4월 미국 제약사 엘리트 파마슈티컬스(Elite Pharmaceuticals)가 퍼코셋(염산옥시코돈-아세트아미노펜정, USP CII)의 제네릭 의약품을 출시하였습니다. 이 복합제는 중등도에서 중등도 이상의 통증 관리를 위해 여러 용량으로 제공되며, 중등도에서 중등도 이상의 통증 관리에 적응증을 가지고 있습니다. 옥시코돈의 강력한 진통 효과와 아세트아미노펜을 결합하여 종합적인 통증 완화 효과를 높였습니다. 스케줄 II로 지정된 규제 물질이기 때문에 남용과 의존의 위험이 높기 때문에 신중한 의료적 관리가 필요합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Oxycodone hydrochloride is a strong opioid analgesic used for the management of moderate to severe pain. It acts by binding to opioid receptors in the brain and spinal cord, thereby decreasing the perception of pain. It is widely prescribed for pain control following surgery or injury, as well as for chronic pain conditions.

The main product forms of oxycodone hydrochloride include extended-release tablets, immediate-release tablets, oral solutions, and extended-release capsules. Extended-release tablets are formulated to gradually release the active ingredient over an extended period, helping to maintain stable drug levels and reduce the need for frequent dosing. Oxycodone hydrochloride is administered via oral and parenteral routes and is commonly used in pain management, including post-surgical pain and cancer-related pain. The product is distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies, and it is used by end users including hospitals, clinics, and homecare settings.

Tariffs have affected the oxycodone hydrochloride market by increasing costs associated with imported active pharmaceutical ingredients and specialized manufacturing equipment. Product segments such as extended release tablets and capsules are more impacted due to complex production requirements, with North America and parts of Asia-Pacific experiencing notable cost pressures. These tariffs have contributed to higher pricing and supply chain adjustments. However, they have also encouraged domestic API production, strengthened local manufacturing capabilities, and supported long-term supply security.

The oxycodone hydrochloride market research report is one of a series of new reports from The Business Research Company that provides oxycodone hydrochloride market statistics, including oxycodone hydrochloride industry global market size, regional shares, competitors with a oxycodone hydrochloride market share, detailed oxycodone hydrochloride market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone hydrochloride industry. This oxycodone hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oxycodone hydrochloride market size has grown steadily in recent years. It will grow from $4.32 billion in 2025 to $4.49 billion in 2026 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to increasing prevalence of chronic pain conditions, widespread use of opioids in post-surgical care, limited availability of alternative pain therapies, strong hospital-based prescribing practices, established oral opioid formulations.

The oxycodone hydrochloride market size is expected to see steady growth in the next few years. It will grow to $5.18 billion in 2030 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to development of abuse-deterrent and tamper-resistant formulations, growing focus on controlled and regulated opioid use, expansion of generic drug manufacturing, rising cancer incidence and palliative care demand, innovation in pain management delivery systems. Major trends in the forecast period include rising demand for effective pain management therapies, growing use of extended release and abuse-deterrent formulations, increasing prescriptions for post-surgical and cancer-related pain, shift toward generic and cost-effective opioid formulations, strengthening regulatory oversight and controlled distribution.

The rising prevalence of chronic pain is anticipated to drive the growth of the oxycodone hydrochloride market in the coming years. Chronic pain, defined as pain lasting for three months or longer, significantly affects patients' quality of life and contributes to increasing demand for effective pain management solutions. The growth in chronic pain cases is mainly linked to factors such as obesity, an aging population, and musculoskeletal conditions, which raise the incidence of disorders including osteoarthritis and lower back pain. Oxycodone hydrochloride aids in chronic pain management by acting on pain receptors within the nervous system, delivering relief from moderate to severe pain and enhancing patient comfort and daily functioning. For instance, in November 2024, according to the U.S. National Center for Health Statistics (NCHS), a US-based federal agency, 24.3% of adults in the United States experienced chronic pain, while 8.5% reported high-impact chronic pain that restricts daily life or work activities. Therefore, the increasing prevalence of chronic pain is fueling the growth of the oxycodone hydrochloride market.

Major companies operating in the oxycodone hydrochloride market are increasingly concentrating on the development of advanced formulations, such as combination therapies, to improve pain management outcomes while minimizing the risks associated with opioid dependence. Combination therapies involve the use of two or more medications together to enhance therapeutic effectiveness, address multiple pain pathways, or reduce adverse effects. For example, in April 2025, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, introduced a generic version of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This combination product is offered in multiple strengths and is indicated for the management of moderate to moderately severe pain, combining the strong analgesic effect of oxycodone with acetaminophen to enhance overall pain relief. As a Schedule II controlled substance, it has a high potential for abuse and dependence, necessitating careful medical oversight.

In June 2024, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, partnered with Nostrum Laboratories Inc. to acquire three approved abbreviated new drug applications (ANDAs) for generic versions of Norco, Percocet, and Dolophine. Through this collaboration, the companies aim to broaden their portfolio of generic opioid analgesics, strengthen their position in the pain management market, and increase the availability of cost-effective alternatives to branded pain medications. Nostrum Laboratories Inc. is a US-based pharmaceutical company that manufactures prescription products, including formulations that combine oxycodone hydrochloride and acetaminophen.

Major companies operating in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Purdue Pharma L.P., Alvogen Inc., Camber Pharmaceuticals, Noramco Inc., Rhodes Pharmaceuticals L.P., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Apotex Inc., Mylan N.V., Cipla Ltd., Torrent Pharmaceuticals Ltd., Sandoz International GmbH, Pfizer Inc., Novartis AG, Accord Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG

North America was the largest region in the oxycodone hydrochloride market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone hydrochloride market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oxycodone hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oxycodone hydrochloride market consists of sales of oxycodone injectable formulations, oxycodone nasal sprays, oxycodone suppositories, and percocet. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Hydrochloride Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oxycodone hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oxycodone hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oxycodone hydrochloride market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Extended Release Tablets; Immediate Release Tablets; Oral Solutions
• 2) By Route Of Administration: Oral; Parental
• 3) By Application: Pain Management; Post Surgical Pain; Cancer Related Pain
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Clinics; Homecare
• Subsegments:
• 1) By Extended Release Tablets: Abuse-Deterrent Formulations; Non-Abuse-Deterrent Formulations
• 2) By Immediate Release Tablets: Combination Products; Single-Agent Formulations
• 3) By Oral Solutions: Concentrated Solutions; Standard Solutions
• Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Endo Pharmaceuticals Inc.; Lupin Ltd.; Mallinckrodt Pharmaceuticals Inc.; ANI Pharmaceuticals Inc.; Purdue Pharma L.P.; Alvogen Inc.; Camber Pharmaceuticals; Noramco Inc.; Rhodes Pharmaceuticals L.P.; Hikma Pharmaceuticals PLC; Amneal Pharmaceuticals LLC; Aurobindo Pharma Ltd.; Zydus Lifesciences Ltd.; Dr. Reddy's Laboratories Ltd.; Apotex Inc.; Mylan N.V.; Cipla Ltd.; Torrent Pharmaceuticals Ltd.; Sandoz International GmbH; Pfizer Inc.; Novartis AG; Accord Healthcare Ltd.; Glenmark Pharmaceuticals Ltd.; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Oxycodone Hydrochloride Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Oxycodone Hydrochloride Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Oxycodone Hydrochloride Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Oxycodone Hydrochloride Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Effective Pain Management Therapies
  • 4.2.2 Growing Use Of Extended Release And Abuse-Deterrent Formulations
  • 4.2.3 Increasing Prescriptions For Post-Surgical And Cancer-Related Pain
  • 4.2.4 Shift Toward Generic And Cost-Effective Opioid Formulations
  • 4.2.5 Strengthening Regulatory Oversight And Controlled Distribution

5. Oxycodone Hydrochloride Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Homecare Settings
• 5.4 Pain Management Centers
• 5.5 Palliative Care Centers

6. Oxycodone Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oxycodone Hydrochloride Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Oxycodone Hydrochloride PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Oxycodone Hydrochloride Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Oxycodone Hydrochloride Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Oxycodone Hydrochloride Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oxycodone Hydrochloride Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oxycodone Hydrochloride Market Segmentation

• 9.1. Global Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Extended Release Tablets, Immediate Release Tablets, Oral Solutions
• 9.2. Global Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Parenteral
• 9.3. Global Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management, Post Surgical Pain, Cancer Related Pain
• 9.4. Global Oxycodone Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Oxycodone Hydrochloride Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Homecare
• 9.6. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Extended Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Abuse-Deterrent Formulations, Non-Abuse-Deterrent Formulations
• 9.7. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Immediate Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Combination Products, Single-Agent Formulations
• 9.8. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Oral Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Concentrated Solutions, Standard Solutions

10. Oxycodone Hydrochloride Market Regional And Country Analysis

• 10.1. Global Oxycodone Hydrochloride Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Oxycodone Hydrochloride Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oxycodone Hydrochloride Market

• 11.1. Asia-Pacific Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oxycodone Hydrochloride Market

• 12.1. China Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oxycodone Hydrochloride Market

• 13.1. India Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oxycodone Hydrochloride Market

• 14.1. Japan Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oxycodone Hydrochloride Market

• 15.1. Australia Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oxycodone Hydrochloride Market

• 16.1. Indonesia Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oxycodone Hydrochloride Market

• 17.1. South Korea Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oxycodone Hydrochloride Market

• 18.1. Taiwan Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oxycodone Hydrochloride Market

• 19.1. South East Asia Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oxycodone Hydrochloride Market

• 20.1. Western Europe Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oxycodone Hydrochloride Market

• 21.1. UK Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oxycodone Hydrochloride Market

• 22.1. Germany Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oxycodone Hydrochloride Market

• 23.1. France Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oxycodone Hydrochloride Market

• 24.1. Italy Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oxycodone Hydrochloride Market

• 25.1. Spain Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oxycodone Hydrochloride Market

• 26.1. Eastern Europe Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oxycodone Hydrochloride Market

• 27.1. Russia Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oxycodone Hydrochloride Market

• 28.1. North America Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oxycodone Hydrochloride Market

• 29.1. USA Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oxycodone Hydrochloride Market

• 30.1. Canada Oxycodone Hydrochloride Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oxycodone Hydrochloride Market

• 31.1. South America Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oxycodone Hydrochloride Market

• 32.1. Brazil Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oxycodone Hydrochloride Market

• 33.1. Middle East Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oxycodone Hydrochloride Market

• 34.1. Africa Oxycodone Hydrochloride Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Oxycodone Hydrochloride Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oxycodone Hydrochloride Market Regulatory and Investment Landscape

36. Oxycodone Hydrochloride Market Competitive Landscape And Company Profiles

• 36.1. Oxycodone Hydrochloride Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Oxycodone Hydrochloride Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Oxycodone Hydrochloride Market Company Profiles
  • 36.3.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Endo Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Lupin Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Oxycodone Hydrochloride Market Other Major And Innovative Companies

• Mallinckrodt Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Purdue Pharma L.P., Alvogen Inc., Camber Pharmaceuticals, Noramco Inc., Rhodes Pharmaceuticals L.P., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Apotex Inc., Mylan N.V., Cipla Ltd.

38. Global Oxycodone Hydrochloride Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oxycodone Hydrochloride Market

40. Oxycodone Hydrochloride Market High Potential Countries, Segments and Strategies

• 40.1 Oxycodone Hydrochloride Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Oxycodone Hydrochloride Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Oxycodone Hydrochloride Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer